Retracted
DOI:
https://doi.org/10.70749/ijbr.v3i3.944Keywords:
Albumin-Bilirubin Score, ALBI, Cirrhosis, Upper Gastrointestinal Bleeding, Mortality, PrognosisAbstract
Introduction: Acute upper gastrointestinal bleeding (AUGIB) is a serious complication of liver cirrhosis with significant mortality. Early risk stratification is crucial. This study aimed to evaluate the diagnostic accuracy of the Albumin-Bilirubin (ALBI) score in predicting in-hospital mortality among cirrhotic patients presenting with AUGIB. Methodology: A descriptive longitudinal study was conducted on 180 patients with liver cirrhosis and AUGIB. The ALBI score was calculated using serum albumin and bilirubin levels. Receiver operating characteristic (ROC) analysis was performed to assess the predictive value of the ALBI score, with stratification based on gender, age, diabetes, hypertension, cirrhosis duration, hospital stay, and Child-Pugh class. Results: The ALBI score showed good overall predictive accuracy with an AUC of 0.816 (95% CI: 0.74–0.89, p=0.001). The optimal cut-off value was -1.50, yielding 90.9% sensitivity and 66.7% specificity. Stratified analysis showed the best performance in females (AUC 0.907), patients aged ≤50 years (AUC 0.850), and diabetics (AUC 0.830). High sensitivity was maintained across most subgroups. Conclusion: This study demonstrates the Albumin-Bilirubin (ALBI) score as a valuable tool for predicting in-hospital mortality in cirrhotic patients with acute upper gastrointestinal bleeding (AUGIB). Unlike traditional scores, ALBI is objective, simple, and based solely on albumin and bilirubin levels. In our cohort of 180 patients, it showed strong predictive performance (AUC 0.816), with a cut-off of -1.5 yielding 90.9% sensitivity and 66.7% specificity. It performed particularly well in females, younger patients, and those with shorter cirrhosis duration. Given the high mortality rate (18.3%), early risk stratification using ALBI may improve outcomes. Further multicenter studies are needed for validation.
Downloads
References
Aluizio CL, Montes CG, Reis GF, Nagasako CK. Risk stratification in acute variceal bleeding: Far from an ideal score. Clinics. 2021;76:e2921. https://doi.org/10.6061/clinics/2021/e2921
De Franchis R, Bosch J, Garcia-Tsao G, Reiberger T, Ripoll C, Abraldes JG, et al. Baveno VII–renewing consensus in portal hypertension. J Hepatol. 2022;76(4):959-74.
Zanetto A, Shalaby S, Feltracco P, Gambato M, Germani G, Russo FP, Burra P, Senzolo M. Recent advances in the management of acute variceal hemorrhage. J Clin Med. 2021;10(17):3818. https://doi.org/10.3390/jcm10173818
Mandorfer M, Aigner E, Cejna M, Ferlitsch A, Datz C, Gräter T, et al. Austrian consensus on the diagnosis and management of portal hypertension in advanced chronic liver disease (Billroth IV). Wiener Klinische Wochenschrift. 2023;135(3):493-523. https://doi.org/10.1007/s00508-023-02229-w
Ma JL, He LL, Jiang Y, Yang JR, Li P, Zang Y, Wei HS. New model predicting gastroesophageal varices and variceal hemorrhage in patients with chronic liver disease. Ann Hepatol. 2020;19(3):287-94. https://doi.org/10.1016/j.aohep.2019.12.007
Yang L, Sun R, Wei N, Chen H. Systematic review and meta-analysis of risk scores in prediction for the clinical outcomes in patients with acute variceal bleeding. Ann Med. 2021;53(1):1806-15. https://doi.org/10.1080/07853890.2021.1990394
Hassanien M, El-Ghannam M, El-Talkawy MD, Abdelrahman Y, El Attar G, Abu Taleb H et al. Risk scoring systems to predict in-hospital mortality in patients with acute variceal bleeding due to hepatitis C virus induced liver cirrhosis. Gastroenterol Insights. 2018;9(1):7629. https://doi.org/10.4081/gi.2018.7629
Zou D, Qi X, Zhu C, Ning Z, Hou F, Zhao J, et al. Albumin-bilirubin score for predicting the in-hospital mortality of acute upper gastrointestinal bleeding in liver cirrhosis: A retrospective study. Turkish J Gastroenterol. 2016;27(2):180-6. https://doi.org/10.5152/tjg.2016.15502
Peng Z, He Z, Guo X, Tacke F, Yang S-S, Sugawara Y, et al. Neutrophil to lymphocyte ratio and albumin-bilirubin score for predicting the in-hospital mortality of hepatocellular carcinoma with acute upper gastrointestinal bleeding. AME Med J. 2017;2. https://doi.org/10.21037/amj.2017.10.02
Ribeiro M, Araujo S, Proença L. ALBI score predicts in-hospital mortality in patients with liver cirrhosis and acute upper gastrointestinal bleeding. Eur J Gastroenterol Hepatol. 2018;30(10):1211-1215.
Zou ZY, Ma XK, Yu YQ, Lu T, Du J, Sun LY. Prognostic role of albumin-bilirubin score in patients with acute variceal bleeding. Turk J Gastroenterol. 2020;31(4):289-294.
Liu X, Li Y, Zhang Z. ALBI score as a predictive model of 30-day mortality after variceal bleeding in cirrhosis. BMC Gastroenterol. 2021;21(1):296.
Chen Q, Kong Y, Zhang L. Performance of the ALBI grade in predicting mortality and liver-related events in compensated cirrhosis. BMC Gastroenterol. 2021;21(1):30.
Hsieh YC, Chen CH, Wang YW. Comparative performance of ALBI, Child-Pugh, and MELD scores in predicting mortality in cirrhosis. PLoS One. 2020;15(2):e0228570.
Tada T, Kumada T, Toyoda H. ALBI score for predicting mortality in cirrhotic patients with variceal bleeding. Eur J Clin Invest. 2019;47(9):871-877.
Fan Z, Yu J, Lin H. Prognostic value of ALBI score in cirrhosis with upper GI bleeding. Ann Hepatol. 2022;27(2):100720.
Elshaarawy O, Farid M, Abdel-Razek W. Prognostic value of ALBI score compared to Child-Pugh score and MELD in cirrhosis with variceal bleeding. Clin Exp Hepatol. 2020;6(4):314-319.
Wu SJ, Lin YX, Ye H. ALBI score as a predictor of survival in cirrhotic patients with GI bleeding. Medicine (Baltimore). 2021;95(24): e3237.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Indus Journal of Bioscience Research
This work is licensed under a Creative Commons Attribution 4.0 International License.
